Weekly Digest - Feb 2024
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
Weekly Digest - Feb 2024
07 Feb 2024: Samsung Biologics and LegoChem Sign ADC Partnership Agreement
- Samsung Biologics, a global CDMO, has signed an agreement with LegoChem Biosciences, a biotech company specializing in ADC programs
- The partnership involves Samsung Biologics providing antibody development and drug substance manufacturing services for LegoChem’s ADC program targeting solid tumors
- LegoChem aims to submit an Investigational New Drug application to the FDA by the first half of 2025, with promising non-clinical efficacy data
- The collaboration seeks to develop efficient and safe therapeutics, with Samsung Biologics leveraging its expertise in ADC development and manufacturing to support LegoChem’s innovative pipeline
